Just in time for Easter, the market delivered two consecutive sessions of gains. All three of the major U.
Zosano Pharma Corp (NASDAQ:ZSAN) received official written notification of an Office action from the U.S.
Zosano Pharma Corp (NASDAQ:ZSAN) reported financial results for the first quarter ended March 31, 2017. In addition, John P.
Zosano Pharma Corp (NASDAQ:ZSAN) investors are wildly disappointed today after the medical patch maker announced the pricing of an underwritten public offering of …
Zosano Pharma Corp (NASDAQ:ZSAN) announced financial results for the fourth quarter and year ended December 31, 2016. “The past year was an important …
Zosano Pharma Corp (NASDAQ:ZSAN) shares skyrocketed over 170% in the past three days, after the company reported positive pivotal trial data for its M207 migraine …
